Tag: Oncology

Invivoscribe, Complete Genomics to develop biomarker tests for oncology research

businessnewstoday- June 3, 2023

Invivoscribe and Complete Genomics have announced a partnership aimed at developing and commercializing biomarker tests on the latter’s next-generation sequencing (NGS) platforms. The collaboration, covering ... Read More

Legend Biotech announces submission of CARVYKTI application to EMA for multiple myeloma

businessnewstoday- May 28, 2023

Legend Biotech has announced the submission of a Type II variation application to the European Medicines Agency (EMA) for CARVYKTI (ciltacabtagene autoleucel or cilta-cel), based ... Read More

Hanx Biopharmaceuticals set to begin US clinical trial of HX009 in lymphoma

businessnewstoday- May 22, 2023

Hanx Biopharmaceuticals (HanxBio) has obtained approval from the US Food and Drug Administration (FDA) for its investigational new drug (IND) of HX009, enabling the company ... Read More

Genmab gets EPKINLY FDA approval for diffuse large B-cell lymphoma

businessnewstoday- May 21, 2023

Danish biotech company Genmab has secured accelerated approval for EPKINLY (epcoritamab-bysp) from the US Food and Drug Administration (FDA) for the treatment of relapsed or ... Read More

LaNova Medicines, AstraZeneca sign $600m worth licensing deal for LM-305

businessnewstoday- May 14, 2023

LaNova Medicines has signed an exclusive license deal worth over $600 million for its pre-clinical stage antibody drug conjugate (ADC) called LM-305 with AstraZeneca. LM-305 ... Read More

Quest Diagnostics to add ctDNA detection technology with Haystack Oncology

businessnewstoday- April 30, 2023

Quest Diagnostics, an American diagnostic information services provider, has agreed to acquire early-stage oncology company Haystack Oncology in an all-cash deal worth up to $450 ... Read More

ImmunoGen to get nearly $175m financing from Pharmakon Advisors

Raghuram Kadari- April 8, 2023

ImmunoGen, a US-based biotechnology company, will receive a non-dilutive term loan financing facility for up to $175 million from entities managed by Pharmakon Advisors. The ... Read More

Glenmark Pharmaceuticals set to begin clinical trial of GRC 54276 in US

businessnewstoday- March 17, 2023

Glenmark Pharmaceuticals, through its subsidiary Glenmark Specialty, is set to begin a first-in-human, phase 1/2 clinical study of GRC 54276 in the US for the ... Read More

Pfizer to acquire cancer drugmaker Seagen for $43bn in cash

Raghuram Kadari- March 16, 2023

American pharmaceutical and biotechnology company Pfizer has agreed to acquire cancer drugmaker Seagen (formerly Seattle Genetics) for $229 per share or $43 billion in cash, ... Read More

Sesen Bio gets shareholders’ approval for merger with Carisma Therapeutics

businessnewstoday- March 4, 2023

Nasdaq-listed Sesen Bio said that its stockholders have approved the previously announced merger deal with Carisma Therapeutics aimed at creating a clinical-stage biotechnology company for ... Read More